Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Covalent albumin microparticles as an adjuvant for production of mucosal vaccines against hepatitis B.

Sitta DL, Guilherme MR, Garcia FP, Cellet TS, Nakamura CV, Muniz EC, Rubira AF.

Biomacromolecules. 2013 Sep 9;14(9):3231-7. doi: 10.1021/bm400859z. Epub 2013 Aug 2.

PMID:
23863080
2.

Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen.

Bhowmik T, D'Souza B, Uddin MN, D'Souza MJ.

J Drug Target. 2012 May;20(4):364-71. doi: 10.3109/1061186X.2012.662686. Epub 2012 Feb 18.

PMID:
22339323
3.

Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.

Schiött A, Larsson K, Manniche S, Kalliomäki S, Heydenreich AV, Dalsgaard K, Kirkby N.

Int J Pharm. 2011 Jul 29;414(1-2):312-20. doi: 10.1016/j.ijpharm.2011.05.026. Epub 2011 May 12.

PMID:
21601626
4.

Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.

Mulder AM, Carragher B, Towne V, Meng Y, Wang Y, Dieter L, Potter CS, Washabaugh MW, Sitrin RD, Zhao Q.

PLoS One. 2012;7(4):e33235. doi: 10.1371/journal.pone.0033235. Epub 2012 Apr 6.

5.
6.

Drug release mechanisms of chemically cross-linked albumin microparticles: effect of the matrix erosion.

Sitta DL, Guilherme MR, da Silva EP, Valente AJ, Muniz EC, Rubira AF.

Colloids Surf B Biointerfaces. 2014 Oct 1;122:404-13. doi: 10.1016/j.colsurfb.2014.07.014. Epub 2014 Jul 19.

PMID:
25087021
7.

Novel preparation techniques for alginate-poloxamer microparticles controlling protein release on mucosal surfaces.

Moebus K, Siepmann J, Bodmeier R.

Eur J Pharm Sci. 2012 Feb 14;45(3):358-66. doi: 10.1016/j.ejps.2011.12.004. Epub 2011 Dec 8.

PMID:
22178531
8.
9.

Lipid microparticles for mucosal immunization against hepatitis B.

Saraf S, Mishra D, Asthana A, Jain R, Singh S, Jain NK.

Vaccine. 2006 Jan 9;24(1):45-56. Epub 2005 Aug 8.

PMID:
16122855
10.

Improvement of hepatitis B vaccine by the use of a new adjuvant.

Byars NE, Nakano G, Welch M, Lehman D, Allison AC.

Vaccine. 1991 May;9(5):309-18.

PMID:
1872014
11.
12.

Zinc-alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying.

Möbus K, Siepmann J, Bodmeier R.

Eur J Pharm Biopharm. 2012 May;81(1):121-30. doi: 10.1016/j.ejpb.2012.01.018. Epub 2012 Feb 8.

PMID:
22342605
13.

Hepatitis B vaccine produced in yeast.

Bitter GA, Egan KM, Burnette WN, Samal B, Fieschko JC, Peterson DL, Downing MR, Wypych J, Langley KE.

J Med Virol. 1988 Jun;25(2):123-40.

PMID:
3292698
14.

Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.

Thomas C, Gupta V, Ahsan F.

Pharm Res. 2010 May;27(5):905-19. doi: 10.1007/s11095-010-0094-x. Epub 2010 Mar 16.

PMID:
20232117
15.

Preparation of bovine serum albumin surface-imprinted submicrometer particles with magnetic susceptibility through core-shell miniemulsion polymerization.

Tan CJ, Chua HG, Ker KH, Tong YW.

Anal Chem. 2008 Feb 1;80(3):683-92. doi: 10.1021/ac701824u. Epub 2008 Jan 9.

PMID:
18181645
16.

Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.

Kusonwiriyawong C, Lipipun V, Vardhanabhuti N, Zhang Q, Ritthidej GC.

Pharm Res. 2013 Jun;30(6):1677-97. doi: 10.1007/s11095-013-1014-7. Epub 2013 Mar 13.

PMID:
23483441
17.

A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant.

Karthigesu VD, Allison LM, Ferguson M, Howard CR.

J Med Virol. 1999 Aug;58(4):346-52.

PMID:
10421400
18.

Chitosan-based nanoparticles as a hepatitis B antigen delivery system.

Lebre F, Bento D, Jesus S, Borges O.

Methods Enzymol. 2012;509:127-42. doi: 10.1016/B978-0-12-391858-1.00007-1.

PMID:
22568904
19.

Subunit, recombinant and synthetic hepatitis B vaccines.

Zuckerman AJ.

Scand J Gastroenterol Suppl. 1985;117:27-38. Review.

PMID:
3912963
20.

Characterization of protein-loaded poly(epsilon-caprolactone) microparticles based on a factorial design.

Lin WJ, Huang LI, Chang RR.

J Microencapsul. 2001 Mar-Apr;18(2):183-9.

PMID:
11253935

Supplemental Content

Support Center